Indian Pharma Sector Poised for 19.4% Earnings Growth in Q3 FY25: Report
Robust Domestic Sales, Niche US Launches, and Lower Raw Material Costs Drive Profitability in Pharma and Healthcare Sector
Indian Pharma Sector Poised for 19.4% Earnings Growth in Q3 FY25: Report
© 2025 Media Concepts. All Rights Reserved.
